The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson's disease
Parkinson's disease (PD), as a refractory neurological disorder with complex etiology, currently lacks effective therapeutic agents. Natural products (NPs), derived from plants, animals, or microbes, have shown promising effects in PD models through their antioxidative and anti-inflammatory pro...
Gardado en:
Main Authors: | Kaixia Yang (Author), Zhongyue Lv (Author), Wen Zhao (Author), Guogang Lai (Author), Cheng Zheng (Author), Feiteng Qi (Author), Cui Zhao (Author), Kaikai Hu (Author), Xiao Chen (Author), Fan Fu (Author), Jiayi Li (Author), Guomin Xie (Author), Haifeng Wang (Author), Xiping Wu (Author), Wu Zheng (Author) |
---|---|
Formato: | Libro |
Publicado: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares
-
Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit α-Synuclein Aggregation and Facilitate its Degradation
por: Yuan Zheng, et al.
Publicado: (2018) -
Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson's Disease Model
por: Xiaoxi Ren, et al.
Publicado: (2019) -
Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
por: Hayate Javed, et al.
Publicado: (2019) -
Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease
por: Jay Gupta, et al.
Publicado: (2023) -
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease
por: Serena Vittorio, et al.
Publicado: (2020)